Saturday 17 October 2026
Export PAVM’s income statement to Excel — free account
PAVmed Inc.
PAVM Healthcare Medical Devices
PAVmed Inc.’s revenue for fiscal 2025 (year ended December 2025) was $71,000.00, down 97.6% from fiscal 2024. In the quarter to June 2026, revenue grew 450.0%, EPS grew 96.1% and free cash flow fell 125.6%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.
2.41
0.02
−0.82%
Follow PAVM
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
2 | 2 | 2 | 2 |
+8 more TTM periods Free account |
| (216.61%) | (167.96%) | 59.31% | 8.40% | ||
| (49.05%) | (57.93%) | (10.86%) | (1.73%) | ||
ROIC |
(54.50%) | (45.61%) | (65.64%) | (64.98%) | |
Return on Tangible Assets |
(2,446.98%) | (743.20%) | 30.93% | 9.62% | |
Average Days of Receivables |
52.14 | 90.18 | 77.11 | 37.76 | |
Free Cash Flow per Share |
(1.24) | (3.98) | (7.81) | (4.99) | |
Free Cash Flow |
(7.78) | (6.29) | (5.24) | (3.58) | |
Capital Expenditures |
(0.05) | (0.05) | (0.03) | (0.02) | |
| Other line items | |||||
Cash ROIC |
(20.38%) | (13.58%) | (21.97%) | (13.98%) | |
Accounts Receivable Turnover |
11.79 | 5.67 | 4.30 | 3.05 | |
Accounts Payable Turnover |
0.50 | 0.41 | 0.33 | 0.45 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
1,070.67 | 1,286.00 | 1,135.18 | 689.67 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
5,687.50% | 5,991.76% | 6,326.76% | 11,975.86% | |
Selling, General and Administrative Expense of Revenue |
17,932.14% | 22,480.00% | 24,178.87% | 57,134.48% | |
Share Based Compensation of Revenue |
1,530.36% | 1,128.24% | 2,404.23% | 7,613.79% | |
Interest Coverage |
(1,483.44) | (1,219.75) | (1,038.38) | (917.91) | |
Operating CF/Net income |
0.37 | 0.22 | 1.38 | 5.98 | |
Depreciation/Fixed assets |
1.08 | 1.04 | 1.36 | 1.93 | |
Capex/Depreciation |
(0.66) | (0.57) | (0.30) | (0.13) | |
Revenue per Share |
0.02 | 0.05 | 0.11 | 0.04 | |
Operating CF per Share |
(1.23) | (3.95) | (7.76) | (4.96) | |
Capex per Share |
(0.01) | (0.03) | (0.05) | (0.03) | |
Capex to Sales |
0.46 | 0.55 | 0.44 | 0.72 |
Columns are period end dates